+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

European Female infertility diagnosis and treatment Market 2019-2025

  • ID: 5005505
  • Report
  • January 2020
  • Region: Europe
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Bayer AG
  • Church & Dwight Co., Inc.
  • Clearblue
  • Cook Medical, Inc.
  • Eli Lilly & Co.
  • Genea Ltd.
European Female infertility diagnosis and treatment Market Size, Share & Trends Analysis Report, By Diagnosis (Ovulation Testing, Hysterosalpingography (HSG), Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others (Laparoscopy)), By End-User (Hospitals and Clinics, Homecare, and Pathology and Diagnostic Centers), and Forecast, 2019-2025.

European female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 3.7% during the forecast period. The economies of UK, Germany, Italy, Spain, France, Russia, and the Nordic countries are the major contributors to the market growth in Europe. The Nordic region has been one of the preferred destinations for fertility tourism for most of the couples from Europe, North America, Kenya, and Hong Kong. Increasing success rates of the IVF treatments within the region has resulted in the significant growth of the market in the region. The female infertility diagnosis and treatment market in Europe is driven by various factors that include delayed marriages coupled with late parenthood decisions, and low fertility rates.

European female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.

Some of the major players operating in the European female infertility diagnosis and treatment market include Abbott Laboratories, Inc., Merck KGaA, Cipla Ltd., and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition and product launch to strengthen their presence in European market.

Research Methodology

The market study of the European female infertility diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for existing companies and new entrants into the market, potential investors and venture capitalists, government organizations, and various end-user industries for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. European Female Infertility Diagnosis And Treatment Market Research and Analysis by Diagnosis
2. European Female Infertility Diagnosis And Treatment Market Research and Analysis by Treatment
3. European Female Infertility Diagnosis And Treatment Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of European female infertility diagnosis and treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting European female infertility diagnosis and treatment market.
  • Insights about market determinants which are stimulating European female infertility diagnosis and treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Church & Dwight Co., Inc.
  • Clearblue
  • Cook Medical, Inc.
  • Eli Lilly & Co.
  • Genea Ltd.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight& Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. European Female Infertility Diagnosis And Treatment Market by Diagnosis
5.1.1. Ovulation Testing
5.1.2. Hysterosalpingography (HSG)
5.1.3. Hysteroscopy
5.1.4. Imaging Testing
5.1.5. Ovarian Reserve Testing
5.1.6. Hormonal Level Testing
5.1.7. Genetic Testing
5.1.8. Others (Laparoscopy)
5.2. European Female Infertility Diagnosis And Treatment Market by Treatment
5.2.1. Drugs
5.2.2. Surgery
5.2.3. Intrauterine Insemination (IUI)
5.2.4. Assisted Reproductive Technology (ART)
5.3. European Female Infertility Diagnosis And Treatment Market by End-User
5.3.1. Hospitals and Clinics
5.3.2. Homecare
5.3.3. Pathology and Diagnostic Centers

6. Regional Analysis
6.1. Europe
6.1.1. UK
6.1.2. Germany
6.1.3. Italy
6.1.4. Spain
6.1.5. France
6.1.6. Rest of Europe

7. Company Profiles
7.1. Clearblue
7.2. Ferring International Center S.A
7.3. IVF Tech ApS
7.4. Vitrolife
7.5. Bayer AG
7.6. Pfizer
7.7. Church & Dwight Co., Inc.
7.8. Vitrolife
7.9. Genea Ltd.
7.10. Cook Medical, Inc.
7.11. Eli Lilly & Co.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Clearblue
  • Ferring International Center S.A
  • IVF Tech ApS
  • Vitrolife
  • Bayer AG
  • Pfizer
  • Church & Dwight Co., Inc.
  • Vitrolife
  • Genea Ltd.
  • Cook Medical, Inc.
  • Eli Lilly & Co.
Note: Product cover images may vary from those shown